ATE293702T1 - Chimäre adenovirale vektoren - Google Patents

Chimäre adenovirale vektoren

Info

Publication number
ATE293702T1
ATE293702T1 AT99920929T AT99920929T ATE293702T1 AT E293702 T1 ATE293702 T1 AT E293702T1 AT 99920929 T AT99920929 T AT 99920929T AT 99920929 T AT99920929 T AT 99920929T AT E293702 T1 ATE293702 T1 AT E293702T1
Authority
AT
Austria
Prior art keywords
adenoviral vectors
adenoviral
genome
derived
chimeric adenoviral
Prior art date
Application number
AT99920929T
Other languages
English (en)
Inventor
Majid Mehtali
Monika Lusky
Arend Jan Winter
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE293702T1 publication Critical patent/ATE293702T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10344—Chimeric viral vector comprising heterologous viral elements for production of another viral vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT99920929T 1998-05-27 1999-05-27 Chimäre adenovirale vektoren ATE293702T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806654 1998-05-27
PCT/FR1999/001238 WO1999061638A1 (fr) 1998-05-27 1999-05-27 Vecteurs adenoviraux chimeres

Publications (1)

Publication Number Publication Date
ATE293702T1 true ATE293702T1 (de) 2005-05-15

Family

ID=9526748

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99920929T ATE293702T1 (de) 1998-05-27 1999-05-27 Chimäre adenovirale vektoren

Country Status (9)

Country Link
US (1) US6479290B1 (de)
EP (1) EP1002120B1 (de)
JP (1) JP2004519201A (de)
AT (1) ATE293702T1 (de)
AU (1) AU752148B2 (de)
CA (1) CA2298064A1 (de)
DE (1) DE69924808D1 (de)
ES (1) ES2239841T3 (de)
WO (1) WO1999061638A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136708A1 (en) 1993-06-24 2002-09-26 Graham Frank L. System for production of helper dependent adenovirus vectors based on use of endonucleases
EP1157103A2 (de) * 1999-02-18 2001-11-28 Merck & Co., Inc. Herstellung von helferabhängigen adenovirusvektoren unter verwendung von endonucleasen
US6867022B1 (en) * 2000-01-21 2005-03-15 Regents Of The University Of Michigan Replication deficient adenovirus vectors and methods of making and using them
US20020081707A1 (en) * 2000-06-29 2002-06-27 Donna Armentano Methods for helper-dependent adenoviral vector production
CA2415347A1 (en) * 2000-07-14 2002-01-24 University Of Saskatchewan Adenovirus vectors comprising introns
US6905678B2 (en) * 2001-07-07 2005-06-14 Crucell Holland B.V. Gene delivery vectors with cell type specificity for mesenchymal stem cells
US7264818B2 (en) * 2003-06-10 2007-09-04 University Of Saskatchewan BAV packaging regions and E1 transcriptional control regions
ES2391975T3 (es) * 2003-07-25 2012-12-03 Genvec, Inc. Vacunas a base de vector adenovírico
WO2006039045A2 (en) * 2004-09-01 2006-04-13 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adenoviral vectors able to transduce apcs, potential use in immune response generation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707664B1 (fr) * 1993-07-13 1995-09-29 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
US5707618A (en) * 1995-03-24 1998-01-13 Genzyme Corporation Adenovirus vectors for gene therapy
WO1997045550A2 (en) * 1996-05-31 1997-12-04 Baxter International Inc. Mini-adenoviral vector

Also Published As

Publication number Publication date
ES2239841T3 (es) 2005-10-01
AU752148B2 (en) 2002-09-05
CA2298064A1 (fr) 1999-12-02
DE69924808D1 (de) 2005-05-25
EP1002120B1 (de) 2005-04-20
JP2004519201A (ja) 2004-07-02
AU3832699A (en) 1999-12-13
US6479290B1 (en) 2002-11-12
EP1002120A1 (de) 2000-05-24
WO1999061638A1 (fr) 1999-12-02

Similar Documents

Publication Publication Date Title
AU681705B2 (en) Endosomolytically active particles
ATE277947T1 (de) Antitumorale zusammenstellung von immunogene polypetiden mit veränderter zellokalisierung
HUE037330T2 (hu) rDEN3/4delta30(ME), rDEN2/4delta30(ME) vagy rDEN1/4delta30(ME) rekombináns kiméra dengue virus, amely 30 nukleotidos deléciót tartalmaz (delta 30) a 4-es típusú dengue genom 3' nem-transzlálódó régiójában, ahol a szóban forgó 30 nukleotidos deléció megfelel a TL2 nyél-hurok szerkezetnek
AU6871398A (en) Method for enhancing expression of a foreign or endogenous gene product in pla nts
ATE286067T1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
BR9612359A (pt) Derivado covalente de uma proteína ob composição polipeptídeo quimérico sequência de ácido nucleico vetor de express o replicável célula hospedeira e métodos associados aos mesmos
EP0979101A4 (de) Rekombinanter hunde-adenovirus (cav), welcher exogene dna enthält
UA85536C2 (en) Viral antigens
YU9403A (sh) Anti-dualna antitela integrina, kompozicije, postupci i primene
MY120693A (en) Human bikunin
ATE465266T1 (de) Zusammensetzungen und verfahren zur verpackung von alpavirus-vektoren
DE69924808D1 (de) Chimäre adenovirale vektoren
EP0608261A4 (de) Zusammensetzung aus einem immunreaktiven hepatitis-c-virus-polypeptid.
LT2003107A (en) Pulmonary adminstration of chemically modified insulin
WO2002012525A3 (en) Helper functions for recombinant vector production
IL136634A0 (en) Recombinant noda virus compositions and methods
TW200611910A (en) Interferon-alpha polypeptides and conjugates
CA2285667A1 (en) Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein a
DE60128149D1 (en) Putrescin-n-methyltransferasepromotor
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
WO2003092582A3 (en) Chimeric ebola virus envelopes and uses therefor
WO2002079239A3 (en) Chimeric filovirus glycoprotein
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
WO2002036627A3 (en) Interferons, uses and compositions related thereto
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties